Texas Wound & Lymphedema Center Tomball, TX - 77375

Texas Wound & Lymphedema Center is categorized under Clinics in Tomball, TX and active since 2007.

Texas Wound & Lymphedema Center was established in 2007, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Clinics business, which does work in the B2C market, and is classified as a Clinics, under code number 6214930 by the NAICS.

If you are seeking more information, feel free to contact Lynn Lebouef, Chief Executive Officer at the company’s single location by writing to 605 Holderrieth Boulevard, Tomball, Texas TX 77375 or by phoning (281) 401-7943. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Texas Wound & Lymphedema Center
Contact Person: Lynn Lebouef, Chief Executive Officer
Address: 605 Holderrieth Boulevard, Tomball, Texas 77375
Phone Number: (281) 401-7943
Annual Revenue (USD): $1.000.000 to $2.499.999
Founded: 2007
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Clinics
SIC Code: 8011
NAICS Code: 6214930
Share This Business:

Texas Wound & Lymphedema Center was started in 2007 to provide professional Clinics under the SIC code 8011 and NAICS code 6214930. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.

Feel free to contact Lynn Lebouef, Chief Executive Officer for inquiries that concern Texas Wound & Lymphedema Center by calling the company number (281) 401-7943, as your correspondence is most welcome. Additionally, the physical location of the single location of Texas Wound & Lymphedema Center can be found at the coordinates 30.08882,-95.62392 as well as the street address 605 Holderrieth Boulevard in Tomball, Texas 77375.

For its online presence, you may visit Texas Wound & Lymphedema Center’s website at and engage with its social media outlets through on Twitter and on Facebook.